Curious Results in Myasthenia Gravis Study

An expert presents the results of a phase 2 study on the impact of rituximab on myasthenia gravis.

Source link

Related posts

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer


Author response: Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis


Living With OCD: Guidelines For Family Members


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy